Novartis, the Swiss pharmaceutical major, has announced a substantial increase in net profit for the fourth quarter, largely attributed to the spinoff of ...
Novartis, the Swiss pharmaceutical giant, has once again raised its full-year earnings guidance after reporting robust financial results for the third quarter. The ...